Table 1.
Patient demographics
Characteristic | Patients (N = 92) |
---|---|
Sex at birth, n (%) | |
Male | 36 (39.1) |
Female | 56 (60.9) |
Age at MG diagnosis, years | |
Mean (SD) | 47.6 (19.3) |
Median (IQR) | 50.5 (35–64) |
Race, n (%) | |
White | 70 (76.1) |
Black/African American | 18 (19.6) |
Asian | 2 (2.2) |
American Indian/Alaskan Native | 1 (1.1) |
Other | 1 (1.1) |
Insurance status at eculizumab initiation, n (%)a | |
Medicare | 42 (45.7) |
Medicaid | 8 (8.7) |
Commercial | 45 (48.9) |
Military | 2 (2.2) |
Unknown | 0 |
IQR interquartile range, MG myasthenia gravis, SD standard deviation
aCategories not mutually exclusive